These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 26830838

  • 21. Evaluating the microbial pattern of periprosthetic joint infections of the hip and knee.
    Rosteius T, Jansen O, Fehmer T, Baecker H, Citak M, Schildhauer TA, Geßmann J.
    J Med Microbiol; 2018 Nov; 67(11):1608-1613. PubMed ID: 30207518
    [Abstract] [Full Text] [Related]

  • 22. Duration of prior vancomycin therapy and subsequent daptomycin treatment outcomes in methicillin-resistant Staphylococcus aureus bacteremia.
    Culshaw D, Lamp KC, Yoon MJ, Lodise TP.
    Diagn Microbiol Infect Dis; 2015 Oct; 83(2):193-7. PubMed ID: 26184127
    [Abstract] [Full Text] [Related]

  • 23. Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study.
    Murray KP, Zhao JJ, Davis SL, Kullar R, Kaye KS, Lephart P, Rybak MJ.
    Clin Infect Dis; 2013 Jun; 56(11):1562-9. PubMed ID: 23449272
    [Abstract] [Full Text] [Related]

  • 24. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
    Sader HS, Watters AA, Fritsche TR, Jones RN.
    BMC Infect Dis; 2007 Apr 18; 7():29. PubMed ID: 17442104
    [Abstract] [Full Text] [Related]

  • 25. Retrospective case-control analysis of patients with staphylococcal infections receiving daptomycin or glycopeptide therapy.
    Falcone M, Russo A, Pompeo ME, Vena A, Marruncheddu L, Ciccaglioni A, Grossi P, Mancini C, Novelli A, Stefani S, Venditti M.
    Int J Antimicrob Agents; 2012 Jan 18; 39(1):64-8. PubMed ID: 22047703
    [Abstract] [Full Text] [Related]

  • 26. [Treatment of hemodialysis catheter-associated bacteremia due to methicillin-resistant Staphylococcus aureus by daptomycin lock method].
    Yılmaz H, Mutlu Yılmaz E, Esen S, Sünbül M, Leblebicioğlu H.
    Mikrobiyol Bul; 2012 Jul 18; 46(3):470-4. PubMed ID: 22951659
    [Abstract] [Full Text] [Related]

  • 27. Combination therapy with daptomycin, vancomycin, and rifampin for recurrent, severe bone and prosthetic joint infections involving methicillin-resistant Staphylococcus aureus.
    Antony SJ.
    Scand J Infect Dis; 2006 Jul 18; 38(4):293-5. PubMed ID: 16718933
    [Abstract] [Full Text] [Related]

  • 28. Activity of Different Antistaphylococcal Therapies, Alone or Combined, in a Rat Model of Methicillin-Resistant Staphylococcus epidermidis Osteitis without Implant.
    Albac S, Labrousse D, Hayez D, Anzala N, Bonnot D, Chavanet P, Aslangul E, Croisier D.
    Antimicrob Agents Chemother; 2020 Jan 27; 64(2):. PubMed ID: 31740562
    [Abstract] [Full Text] [Related]

  • 29. Randomized controlled trial of the safety and efficacy of Daptomycin versus standard-of-care therapy for management of patients with osteomyelitis associated with prosthetic devices undergoing two-stage revision arthroplasty.
    Byren I, Rege S, Campanaro E, Yankelev S, Anastasiou D, Kuropatkin G, Evans R.
    Antimicrob Agents Chemother; 2012 Nov 27; 56(11):5626-32. PubMed ID: 22908174
    [Abstract] [Full Text] [Related]

  • 30. In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides.
    Capone A, Cafiso V, Campanile F, Parisi G, Mariani B, Petrosillo N, Stefani S.
    Eur J Clin Microbiol Infect Dis; 2016 Apr 27; 35(4):625-31. PubMed ID: 26815434
    [Abstract] [Full Text] [Related]

  • 31. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
    Claeys KC, Zasowski EJ, Casapao AM, Lagnf AM, Nagel JL, Nguyen CT, Hallesy JA, Compton MT, Kaye KS, Levine DP, Davis SL, Rybak MJ.
    Antimicrob Agents Chemother; 2016 Oct 27; 60(10):5841-8. PubMed ID: 27431221
    [Abstract] [Full Text] [Related]

  • 32. Daptomycin in synovial fluid during treatment of methicillin-resistant Staphylococcus aureus septic arthritis.
    Ritchie ND, Lovering AM, Seaton RA.
    J Antimicrob Chemother; 2010 Jun 27; 65(6):1314-5. PubMed ID: 20382723
    [No Abstract] [Full Text] [Related]

  • 33. Daptomycin therapy failure in an adolescent with methicillin-resistant Staphylococcus aureus bacteremia.
    Jacobson LM, Milstone AM, Zenilman J, Carroll KC, Arav-Boger R.
    Pediatr Infect Dis J; 2009 May 27; 28(5):445-7. PubMed ID: 19295462
    [Abstract] [Full Text] [Related]

  • 34. Use of daptomycin to treat infections with methicillin-resistant Staphylococcus aureus isolates having vancomycin minimum inhibitory concentrations of 1.5 to 2 μg/mL.
    McDaneld PM, Spooner LM, Mohr JF, Belliveau PP.
    Ann Pharmacother; 2013 Dec 27; 47(12):1654-65. PubMed ID: 24259618
    [Abstract] [Full Text] [Related]

  • 35. Clinical experience with daptomycin for the treatment of patients with knee and hip periprosthetic joint infections.
    Corona Pérez-Cardona PS, Barro Ojeda V, Rodriguez Pardo D, Pigrau Serrallach C, Guerra Farfán E, Amat Mateu C, Flores Sanchez X.
    J Antimicrob Chemother; 2012 Jul 27; 67(7):1749-54. PubMed ID: 22511636
    [Abstract] [Full Text] [Related]

  • 36. Ventilator-associated pneumonia by methicillin-susceptible Staphylococcus aureus: do minimum inhibitory concentrations to vancomycin and daptomycin matter?
    Ruiz-Ramos J, Vidal-Cortés P, Díaz-Lamas A, Reig-Valero R, Roche-Campo F, Del Valle-Ortiz M, Nuvials-Casals X, Ortiz-Piquer M, Andaluz-Ojeda D, Tamayo-Lomas L, Blasco-Navalpotro MA, Rodriguez-Aguirregabiria M, Aguado J, Ramirez P.
    Eur J Clin Microbiol Infect Dis; 2017 Sep 27; 36(9):1569-1575. PubMed ID: 28378244
    [Abstract] [Full Text] [Related]

  • 37. Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.
    Arshad S, Huang V, Hartman P, Perri MB, Moreno D, Zervos MJ.
    Int J Infect Dis; 2017 Apr 27; 57():27-31. PubMed ID: 28131729
    [Abstract] [Full Text] [Related]

  • 38. Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration.
    Peeters O, Ferry T, Ader F, Boibieux A, Braun E, Bouaziz A, Karsenty J, Forestier E, Laurent F, Lustig S, Chidiac C, Valour F, Lyon BJI study group.
    BMC Infect Dis; 2016 Nov 03; 16(1):622. PubMed ID: 27809799
    [Abstract] [Full Text] [Related]

  • 39. Daptomycin or vancomycin for methicillin-resistant Staphylococcus aureus with a vancomycin minimum inhibitory concentration >1 μg/L.
    López-Cortés LE, Pascual Á, Rodríguez-Baño J.
    Clin Infect Dis; 2012 May 03; 54(9):1375-6; author reply 1376-7. PubMed ID: 22460977
    [No Abstract] [Full Text] [Related]

  • 40. Implementation of an antimicrobial stewardship pathway with daptomycin for optimal treatment of methicillin-resistant Staphylococcus aureus bacteremia.
    Kullar R, Davis SL, Kaye KS, Levine DP, Pogue JM, Rybak MJ.
    Pharmacotherapy; 2013 Jan 03; 33(1):3-10. PubMed ID: 23307539
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.